About Tambov Regional Oncology Clinical Dispansary
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Janssen Research & Development, LLC
4
Clinical Trials at Tambov Regional Oncology Clinical Dispansary
During the past decade, Tambov Regional Oncology Clinical Dispansary conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Erdafitinib in Participants With Metastatic or Locally Advanced Urothelial Cancer
2018-04-05
2024-01-31
Active, not recruiting
125
A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer
2019-01-25
2027-02-19
Active, not recruiting
765
A Study of Amivantamab and Lazertinib Combination Therapy Versus Osimertinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
2020-09-30
2025-11-18
Active, not recruiting
1,074
A Study of Amivantamab and Lazertinib in Combination With Platinum-Based Chemotherapy Compared With Platinum-Based Chemotherapy in Patients With Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non- Small Cell Lung Cancer After Osimertinib Failure
2021-11-17
2026-12-29
Recruiting
690
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Tambov Regional Oncology Clinical Dispansary
According to Clinical.Site data, the most researched conditions in "Tambov Regional Oncology Clinical Dispansary" are
"Carcinoma, Non-Small-Cell Lung" (2 trials), "Castration-Resistant Prostatic Cancer" (1 trials) and "Urothelial Carcinoma" (1 trials). Many other conditions were trialed in "Tambov Regional Oncology Clinical Dispansary" in a lesser frequency.
Clinical Trials Intervention Types at Tambov Regional Oncology Clinical Dispansary
Most popular intervention types in "Tambov Regional Oncology Clinical Dispansary" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Amivantamab" (2 trials), "Carboplatin" (2 trials), "Lazertinib" (2 trials), "Placebo" (2 trials) and "Abiraterone Acetate" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Tambov Regional Oncology Clinical Dispansary
The vast majority of trials in "Tambov Regional Oncology Clinical Dispansary" are
3 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at Tambov Regional Oncology Clinical Dispansary
Currently, there are NaN active trials in "Tambov Regional Oncology Clinical Dispansary".
undefined are not yet recruiting,
1 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Tambov Regional Oncology Clinical Dispansary,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Tambov Regional Oncology Clinical Dispansary, 1 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".